Skip to main content
. 2014 Mar 26;9(3):e93103. doi: 10.1371/journal.pone.0093103

Figure 1. Schematic of the construction of oncolytic HSV2-GFP and HSV2.

Figure 1

The two oncolytic HSV2 vectors were developed from the HG52 strain. Modifications include deletion of the ICP47 and ICP34.5 genes and insertion of a GFP expression cassette.